CASP3 and hepatocellular carcinoma: The iSGLT2 canagliflozin-mediated cytotoxicity has been related to cell cycle arrest in G1 or G1/S phase and apoptotic cell death via caspase-3 activation in hepatocellular carcinoma and lung and thyroid cancer cells [60–62].